Pages that link to "Q33941796"
Jump to navigation
Jump to search
The following pages link to Discovery research: the scientific challenge of finding new antibiotics (Q33941796):
Displaying 50 items.
- The evolutionary rate of antibacterial drug targets (Q21093648) (← links)
- Whole-genome sequencing targets drug-resistant bacterial infections (Q26799059) (← links)
- Novel derivatives of polymyxins (Q26824934) (← links)
- Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA (Q26995305) (← links)
- Impact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change (Q27310224) (← links)
- Chemical profiling, antimicrobial and insecticidal evaluations of Polygonum hydropiper L (Q28817876) (← links)
- High-throughput screening of a diversity collection using biodefense category A and B priority pathogens (Q30541139) (← links)
- Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis (Q33641697) (← links)
- In vitro synergistic effect of curcumin in combination with third generation cephalosporins against bacteria associated with infectious diarrhea (Q33736172) (← links)
- Growing unculturable bacteria (Q34290686) (← links)
- The enzymes of β-lactam biosynthesis (Q34310470) (← links)
- The 2012 Garrod lecture: discovery of antibacterial drugs in the 21st century (Q34470233) (← links)
- Systems-level antimicrobial drug and drug synergy discovery (Q34626969) (← links)
- Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. (Q34922438) (← links)
- Trends in the frequency of original research in acne vulgaris, rosacea, dermatitis, psoriasis, skin cancer, and skin infections, 1970-2010. (Q35043254) (← links)
- Meleagrin, a new FabI inhibitor from Penicillium chryosogenum with at least one additional mode of action (Q35060154) (← links)
- Use of computer decision support in an antimicrobial stewardship program (ASP). (Q35227227) (← links)
- Changing the narrative on antibiotics (Q35561392) (← links)
- Microscale Adaptation of In Vitro Transcription/Translation for High-Throughput Screening of Natural Product Extract Libraries (Q35683997) (← links)
- Targets for Combating the Evolution of Acquired Antibiotic Resistance (Q35754447) (← links)
- Antimicrobial use in swine production and its effect on the swine gut microbiota and antimicrobial resistance. (Q35790394) (← links)
- Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway (Q35924624) (← links)
- Consolidating Russia and Eurasia Antibiotic Resistance Data for 1992-2014 Using Search Engine (Q35970065) (← links)
- Resveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants (Q35979673) (← links)
- In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens (Q36018796) (← links)
- Current epidemiology and growing resistance of gram-negative pathogens (Q36025192) (← links)
- Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro. (Q36075871) (← links)
- Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects (Q36290773) (← links)
- Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents. (Q36364252) (← links)
- Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial. (Q36633761) (← links)
- β-Lactam Antibiotics Renaissance (Q36683689) (← links)
- Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? (Q36757725) (← links)
- Development of a web-based tool for automated processing and cataloging of a unique combinatorial drug screen (Q37038087) (← links)
- Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage (Q37544570) (← links)
- Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment (Q37604241) (← links)
- Essential oils, a new horizon in combating bacterial antibiotic resistance (Q37632354) (← links)
- Antibiotic research in the age of omics: from expression profiles to interspecies communication (Q37935395) (← links)
- Ethical dilemmas in antibiotic treatment (Q37943287) (← links)
- Fourteen years in resistance (Q37990212) (← links)
- Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes (Q38035276) (← links)
- Viable screening targets related to the bacterial cell wall. (Q38070780) (← links)
- An in silico structure-based approach to anti-infective drug discovery (Q38114581) (← links)
- Discovery and preclinical development of new antibiotics. (Q38197284) (← links)
- Computational methods to identify new antibacterial targets (Q38224191) (← links)
- Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health (Q38414823) (← links)
- Unconventional screening approaches for antibiotic discovery (Q38534653) (← links)
- Strategies for target identification of antimicrobial natural products (Q38710256) (← links)
- Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives. (Q38786216) (← links)
- Simulation model to predict the fate of ciprofloxacin in the environment after wastewater treatment. (Q40094903) (← links)
- Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741. (Q40202934) (← links)